BioSpace

Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

CEO Matt Gline is juggling Roivant Sciences' first solo drug launch and several maturing programs as the hub-and-spoke company sets its sights on a massive turning point into commercial viability.

Por BioSpace

1 minuto de lectura
Compartir
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas